Interaction maps for kinase inhibitors

Nature Biotechnology

Volumn 23, Issue 3, 2005, Pages 308-309

  Griffin, James D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PHOSPHOTRANSFERASE INHIBITOR; DRUG; ESCHERICHIA COLI PROTEIN; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE;

ANALYTIC METHOD; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; GENE MUTATION; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR INTERACTION; PRIORITY JOURNAL; RELIABILITY; SHORT SURVEY; DRUG DESIGN; ESCHERICHIA COLI; METABOLISM; METHODOLOGY; NOTE; PROTEIN ANALYSIS; PROTEIN BINDING;

DRUG DESIGN; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; PHARMACEUTICAL PREPARATIONS; PIPERAZINES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 20444473502     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0305-308     Document Type: Short Survey

References (13)

1. Fabian, M.A. et al. Nat. Biotechnol. 23, 329-336 (2005).
2. O'Brien, S.G. et al. New Eng. J. Med. 348, 994-1004 (2003).
3. Buchdunger, E. et al. J. Pharmacol. Exp. Ther. 295, 139-145 (2000).
4. Demetri, G.D. et al. N. Engl. J. Med. 347, 472-480 (2002).
5. Cools, J. et al. N. Engl. J. Med. 348, 1201-1214 (2003).
6. Shah, N.P. et al. Science 305, 399-401 (2004).
7. Weisberg, E. et al. Cancer Cell, 7, 129-141 (2005).
8. Wang, Z. et al. Science 304, 1164-1166 (2004)
9. Paez, J.G. et al. Science 304, 1497-500 (2004).
10. Lynch, T.J. et al. N. Engl. J. Med. 350, 2129-2139 (2004).
11. Stone, R.M. et al. Blood 105, 54-60(2005).
12. Davies, H. et al. Nature 417, 949-954 (2002).
13. Samuels, Y. et al. Science 304, 554 (2004).